Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

Código QR

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

Diego Novick,1 William Montgomery,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Gang Zhu,4 Li Yue,5 Jihyung Hong,6 Héctor Dueñas,7 Roberto Brugnoli8 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Parc Sanitari Sant Joan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Depression Antidepressant Duloxetine SSRI Functioning Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/817d96775c9744fba77c329c4524847d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider M, et al.
Publicado: (2017)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
por: Kuga A, et al.
Publicado: (2017)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada E, et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
por: Atmaca M
Publicado: (2020)

Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Jiaojiao Zhou, et al.
Publicado: (2021)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Najmeh Shahini, et al.
Publicado: (2021)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
por: Rosenberg T, et al.
Publicado: (2017)

Update on duloxetine for the management of stress urinary incontinence
por: Maya Basu, et al.
Publicado: (2008)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
por: Larisa Duffy, et al.
Publicado: (2021)

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Russell J, et al.
Publicado: (2010)

Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
por: Xin KZ, et al.
Publicado: (2019)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
por: Maneeton B, et al.
Publicado: (2018)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga A, et al.
Publicado: (2019)

Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial
por: Yue L, et al.
Publicado: (2019)

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study
por: Castellano S, et al.
Publicado: (2020)

The noradrenergic paradox: implications in the management of depression and anxiety
por: Montoya A, et al.
Publicado: (2016)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang J, et al.
Publicado: (2018)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017)

EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: I Putu Eka Widyadharma, et al.
Publicado: (2021)

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
por: Yamaguchi Y, et al.
Publicado: (2018)

Evaluating the Effect of Preoperative Duloxetine Administration on Postoperative Pain in Patients under Abdominal Hysterectomy
por: H Sattari, et al.
Publicado: (2020)

COMPARATIVE STUDY OF EFFECTIVENESS OF VENLAFAXINE, DULOXETINE AND SERTRALINE IN MANAGEMENT OF DIABETIC SENSORY NEUROPATHY
por: Nabila Shaukat, et al.
Publicado: (2021)

Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
por: Yakimova R., et al.
Publicado: (2020)

El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
por: LEYTON A,FANNY, et al.
Publicado: (2010)

Psicofarmacoterapia antidepresiva
por: Retamal C,Pedro
Publicado: (2001)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Mike Briley, et al.
Publicado: (2010)

Trastorno disfórico premenstrual
por: López-Mato,Andrea, et al.
Publicado: (2000)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
por: Zhang L, et al.
Publicado: (2016)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
por: Bhattacharjee S, et al.
Publicado: (2020)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick D, et al.
Publicado: (2016)

Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies
por: Elsenosy FM, et al.
Publicado: (2020)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
por: L. K. Khokhlov, et al.
Publicado: (2019)

¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
por: Silva,Hernán, et al.
Publicado: (2007)

Farmacoterapia de los trastornos depresivos unipolares en la mujer
por: Rees,Reginald
Publicado: (2002)

A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
por: Cui YH, et al.
Publicado: (2016)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
por: Michael Colla, et al.
Publicado: (2021)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata R, et al.
Publicado: (2016)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
por: Blat Diana, et al.
Publicado: (2021)